AZNCF - Amgen's Earnings And Other News: The Good Bad And Ugly Of Biopharma
Amgen reports better than expected Q2 numbers, raises guidance
Amgen (AMGN) reported its second quarter earnings, generally besting the market estimates. The company’s earnings per share stood at $4.25, up 7.05 percent on a year-over-year basis. It also surpassed the market expectation of $3.84 in earnings per share.
Amgen reported that despite the onslaught of the coronavirus pandemic, its revenue grew 6 percent on a year-over-year basis to $6.2 billion for the second quarter of the year. However, its GAAP earnings per share declined 15 percent to $3.05, owing to amortization costs associated